CardioVia
PrivateLast Round
Grant
May 1, 2019
Total Funding Raised
$56,000
Company Overview
CardioVia is a medical device company that develops minimally invasive technology for safe and precise access to the heart's surface (pericardial space) to treat cardiovascular diseases and arrhythmias.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioVia Comparables
Compare CardioVia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiEP, Inc. | 87% | |
| CIRCA Scientific | 85% | |
| CorNav Corporation | 81% | |
CardioVia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2019 | ||||
| Seed | Apr 25, 2018 |
Key People
Founding team and executive leadership
CardioVia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
| NGT HealthCare II | Seed |
| Yissum Research Development Company of the Hebrew University of Jerusalem | Seed |
| Hadasit - Hadassah Medical Center's Technology Transfer Company | Seed |
CardioVia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CardioVia's valuation, stock price, and market status.